Oleksandr Zhurakovskyi

Title: Oleksandr Zhurakovskyi: Innovator in FGFR Inhibitors

Introduction

Oleksandr Zhurakovskyi is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His work is characterized by a focus on innovative methods and compounds that have the potential to impact medical treatments.

Latest Patents

Zhurakovskyi holds a patent for "FGFR inhibitors and methods of making and using the same." This patent is directed towards crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide. The patent also covers its salts, cocrystals, and variants thereof. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Zhurakovskyi is currently associated with Relay Therapeutics, Inc., where he continues to advance his research in the pharmaceutical sector. His work at Relay Therapeutics emphasizes the importance of precision medicine and targeted therapies.

Collaborations

He has collaborated with notable colleagues such as André Lescarbeau and Jethro Beamish-Cook. These partnerships highlight the collaborative nature of research and innovation in the pharmaceutical industry.

Conclusion

Oleksandr Zhurakovskyi is a prominent figure in the field of FGFR inhibitors, with a focus on innovative pharmaceutical solutions. His contributions and collaborations reflect his commitment to advancing medical science.